These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8335037)

  • 1. Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment.
    Smith DA
    Eur J Drug Metab Pharmacokinet; 1993; 18(1):31-9. PubMed ID: 8335037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics in toxicology.
    Smith DA
    Xenobiotica; 1997 May; 27(5):513-25. PubMed ID: 9179991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics in veterinary medicine.
    Baggot JD
    Clin Pharmacokinet; 1992 Apr; 22(4):254-73. PubMed ID: 1606786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies comparisons in toxicology: the utility and futility of plasma concentrations of the test substance.
    Monro AM
    Regul Toxicol Pharmacol; 1990 Oct; 12(2):137-60. PubMed ID: 2259755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues related to the use of canines in toxicologic pathology--issues with pharmacokinetics and metabolism.
    Tibbitts J
    Toxicol Pathol; 2003; 31 Suppl():17-24. PubMed ID: 12597427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug toxicokinetics: scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses.
    Monro A
    J Pharmacokinet Biopharm; 1994 Feb; 22(1):41-57. PubMed ID: 8027948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug dosage in the elderly. Is it rational?
    Turnheim K
    Drugs Aging; 1998 Nov; 13(5):357-79. PubMed ID: 9829164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On setting the first dose in man: quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models.
    Lowe PJ; Tannenbaum S; Wu K; Lloyd P; Sims J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):195-209. PubMed ID: 20050847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the safety and pharmacodynamics of human fibrinogen concentrate in animals.
    Beyerle A; Nolte MW; Solomon C; Herzog E; Dickneite G
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):70-7. PubMed ID: 25102310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic modeling in vivo.
    Holford NH; Sheiner LB
    Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models for assessing the relationship between drug concentration and drug effect in performance horses.
    Kamerling SG; Owens JG
    Br Vet J; 1994; 150(6):507-25. PubMed ID: 7850442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimising in vivo pharmacology studies--Practical PKPD considerations.
    Gabrielsson J; Green AR; Van der Graaf PH
    J Pharmacol Toxicol Methods; 2010; 61(2):146-56. PubMed ID: 20153442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maxsim2 - Real-time interactive simulations for computer-assisted teaching of pharmacokinetics and pharmacodynamics.
    Gabrielsson J; Andersson K; Tobin G; Ingvast-Larsson C; Jirstrand M
    Comput Methods Programs Biomed; 2014 Mar; 113(3):815-29. PubMed ID: 24461798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difficulties in using animal data to predict pharmacological response in man.
    Jenden DJ
    Neurosci Biobehav Rev; 1991; 15(1):105-7. PubMed ID: 2052181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic relationship.
    Baggot JD
    Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between pharmacokinetics and toxicokinetics.
    Welling PG
    Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.